Please assess the completion status of the following clinical trial:

Trial Title: Pediatric Postoperative Analgesia With Quadratus Lumborum Block(QLB) And Dexamethasone As An Adjuvant To Bupivacaine.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Pediatric patients(6-12 years)~* ASA physical status I,II~* Abdominal surgery~Exclusion Criteria:~* Parents refusal or legal guardian's refusal~* Allergy to bupivacaine or dexamethasone~* Contraindications to regional techniques~* Failed QLB~* Infection on site of procedure

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 12 Years
- Healthy Volunteers: t

Study Arms:
- Group A Quadratus Lumborum Block with dexamethasone IV (Type: ACTIVE_COMPARATOR): QLB with (0.5 mL/kg of bupivacaine 0.25%) and IV dexamethasone (0.1-0.3 mg/kg with a maximum dose 10 mg) added to 5 mL normal saline
- Group B Quadratus Lumborum Block with dexamethasone locally (Type: ACTIVE_COMPARATOR): QLB with (0.5 mL/kg of bupivacaine 0.25% plus dexamethasone 0.1 mg/kg), and IV 5 mL normal saline
- Group C Quadratus Lumborum Block with bupivacaine alone (Type: PLACEBO_COMPARATOR): Patients will receive QLB (0.5 mL/kg of bupivacaine 0.25%) and IV 5 mL normal saline.

Based on this trial design, predict the completion outcome and termination type (if applicable).